Distinguishing active HIV-1 infection from vaccine-induced seropositivity in HIV vaccine trial participants
Ketan Dighe(University of Maryland, Baltimore County), Dipanjan Pan(Pennsylvania State University), David Skrodzki(Pennsylvania State University), Parikshit Moitra(Indian Institute of Science Education and Research Berhampur), Maha Alafeef(University of Maryland, Baltimore), Teresa Aditya(Pennsylvania State University), Nivetha Gunaseelan(Pennsylvania State University), Casey N. Pinto(Pennsylvania State University), Oğuzhan Çolak(Pennsylvania State University), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Pranay Saha(Indian Association for the Cultivation of Science)
Cited by 3
Related Papers
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
|New England Journal of Medicine|2013|586
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557
Functions of IL-4 and Control of Its Expression
|Critical Reviews in Immunology|2017|354